Decreased protein kinase C (PKC) in platelets of pediatric bipolar patients: Effect of treatment with mood stabilizing drugs

Journal of Psychiatric Research

Volumn 42, Issue 2, 2008, Pages 106-116

  Pandey, Ghanshyam N ^a   Ren, Xinguo ^a   Dwivedi, Yogesh ^a   Pavuluri, Mani N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Lithium; Mood stabilizing drugs; Pediatric bipolar disorder; PKC activity; PKC isozymes; Platelets

Indexed keywords

ARIPIPRAZOLE; LAMOTRIGINE; LITHIUM; OXCARBAZEPINE; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA I; PROTEIN KINASE C BETA II; PROTEIN KINASE C DELTA; RISPERIDONE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANTIBODY LABELING; ARTICLE; BIPOLAR DISORDER; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOSOL; CYTOSOLIC FRACTION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MEMBRANE; PATHOPHYSIOLOGY; PEDIATRICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; SYMPTOM; THERAPY EFFECT; THROMBOCYTE;

ADOLESCENT; ANTICONVULSANTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BLOOD PLATELETS; CHILD; FEMALE; HUMANS; ISOENZYMES; LITHIUM CARBONATE; MALE; PROTEIN KINASE C; PSYCHIATRIC STATUS RATING SCALES; REFERENCE VALUES; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 35848952504     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2006.11.004     Document Type: Article

References (51)

1. Abeliovich A., Chen C., Goda Y., Silva A.J., Stevens C.F., and Tonegawa S. Modified hippocampal long-term potentiation in PKC gamma-mutant mice. Cell 75 (1993) 1253-1262
2. Aderem A. The MARCKS brothers: a family of protein kinase C substrates. Cell 71 (1992) 713-716
3. Allen L.H., and Aderem A. A role for MARCKS, the alpha isozyme of protein kinase C and myosin I in zymosan phagocytosis by macrophages. Journal of Experimental Medicine 182 (1995) 829-840
4. Allison J.H., and Stewart M.A. Reduced brain inositol in lithium-treated rats. Nature New Biology 233 (1971) 267-268
5. Berridge M.J., and Irvine R.F. Inositol phosphates and cell signaling. Nature 341 (1989) 197-205
6. Bezchlibnyk Y., and Young L.T. The neurobiology of bipolar disorder: focus on signal transduction pathways and the regulation of gene expression. Canadian Journal of Psychiatry 47 (2002) 135-148
7. Casebolt T.L., and Jope R.S. Effect of chronic lithium treatment on protein kinase C and cyclic AMP-dependent protein phosphorylation. Biological Psychiatry 29 (1991) 233-243
8. Casabona G. Intracellular signal modulation: a pivotal role for protein kinase C. Prog Neuropsychopharmacol Biological Psychiatry 21 (1997) 407-425
9. Dwivedi Y., and Pandey G.N. Administration of dexamethasone up-regulates protein kinase C activity and the expression of gamma and epsilon protein kinase C isozymes in the rat brain. Journal of Neurochemistry 72 (1999) 380-387
10. Frey B.N., Andreazza A.C., Kunz M., Gomes F.A., Quevedo J., Salvador M., Goncalves C.A., and Kapczinski F. Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Progress in Neuro-sychopharmacology and Biological Psychiatry 18 Jul (2006) ([Epub ahead of print])
11. Frey B.N., Valvassori S.S., Reus G.Z., Martins M.R., Petronilho F.C., Bardini K., Dal-Pizzol F., Kapczinski F., and Quevedo J. Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. Journal of Psychiatry and Neuroscience 31 (2006) 326-332
12. Friedman E., Wang H.Y.W., Levinson D., Connell T.A., and Singh H. Altered platelet protein kinase C activity in bipolar affective disorder, manic episodes. Biological Psychiatry 33 (1993) 520-525
13. Geller B., Warner K., Williams M., and Zimerman B. Prepubertal and young adolescent bipolarity versus ADHA: Assessment and validity using the WASH-U-KSADS, CBCL, and TRF. Journal of Affective Disorders 51 (1998) 93-100
14. Geller B., Tillman R., Craney J.L., and Bolhofner K. Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Archives of General Psychiatry 61 (2004) 459-467
15. Hallcher L.M., and Sherman W.R. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. Journal of Biological Chemistry 255 (1980) 10896-10901
16. Hayashi S., Ueyama T., Kajimoto T., Yagi K., Kohmura E., and Saito N. Involvement of gamma protein kinase C in estrogen-induced neuroprotection against focal brain ischemia through G protein-coupled estrogen receptor. Journal of Neurochemistry 93 (2005) 883-891
17. Ikonomov O.C., and Manji H.K. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge. American Journal of Psychiatry 156 (1999) 1506-1514
18. Jope R.S. Anti-bipolar therapy: mechanism of action of lithium. Molecular Psychiatry 4 (1999) 117-128
19. Jope R.S., Song L., Li P.P., Young L.T., Kish S.J., Pacheco M.A., et al. The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. Journal of Neurochemistry 66 (1996) 2402-2409
20. Kafantaris V., Coletti D.J., Dicker R., Padula G., and Kane J.M. Adjunctive antipsychotic treatment of adolescents with bipolar psychosis. Journal of the American Academy of Child and Adolescent Psychiatry 40 (2001) 1448-1456
21. Kafantaris V., Dicker R., Coletti D.J., and Kane J.M. Adjunctive antipsychotic treatment is necessary for adolescents with psychotic mania. Journal of Child and Adolescent Psychopharmacology 11 (2001) 409-413
22. Kowatch R.A., Suppes T., Carmody T.J., Bucci J.P., Hume J.H., Kromelis M., et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 39 (2000) 713-720
23. Leitges M., Kovac J., Plomann M., and Linden D.J. A unique PDZ ligand in PKC alpha confers induction of cerebellar long-term synaptic depression. Neuron 44 (2004) 585-594
24. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
25. Manji H.K., and Lenox R.H. Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C. Synapse 16 (1994) 11-28
26. Manji H.K., and Lenox R.H. Protein kinase C signaling in the brain: Molecular transduction of mood stabilization in the treatment of manic depressive illness. Biological Psychiatry 46 (1999) 1328-1351
27. Manji H.K., Etcheberrigaray R., Chen G., and Olds J.L. Lithium decreases membrane-associated protein kinase C in hippocampus: Selectivity for the α-isozyme. Journal of Neurochem 61 (1993) 2302-2310
28. Manji H.K., Potter W.Z., and Lenox R.H. Signal transduction pathways: molecular targets for lithium's action. Archives of General Psychiatry 52 (1995) 531-543
29. Manji H.K., Bebchuk J.M., Moore G.J., Glitz D., Hasanat K.A., and Chen G. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. Journal of Clinical Psychiatry 60 Suppl. 2 (1999) 27-39 discussion 40-41, 113-116
30. Morishita S., and Watanabe S. The direct effect of lithium and carbamazepine on protein kinase C in rat brain. Japanese Journal of Psychiatry and Neurology 48 (1994) 123-126
31. Nestler E.J., and Greengard P. Protein phosphorylation and the regulation of neuronal function. In: Siegel G.H., Albers R.W., Agranoff B.W., and Molinoff P. (Eds). Basic Neurochemistry: Molecular, Cellular, and Medical Aspects (1994), Little, Brown, Boston (MA)
32. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334 (1988) 661-665
33. Nishizuka Y. Intercellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 58 (1992) 607-614
34. Nishizuka Y., Shearman M.S., Oda T., Berry N., Shinomura T., Asaoka Y., et al. Protein kinase C family and nervous function. Progress in Brain Research 89 (1991) 125-141
35. Pacheco M.A., and Jope R.S. Phosphoinositide signaling in human brain. Progress in Neurobiology 50 (1996) 255-273
36. Pandey G.N., Dwivedi Y., SridharaRao J., Ren X., Janicak P.G., and Sharma R. Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients. Neuropsychopharmacology 26 (2002) 216-228
37. Pandey G.N., Pandey S.C., Ren X., Dwivedi Y., and Janicak P.G. Serotonin receptors in platelets of bipolar and schizoaffective patients: effect of lithium treatment. Psychopharmacology (Berl) 70 (2003) 115-123
38. Pavuluri M.N., Birmaher B., and Naylor M.W. Pediatric bipolar disorder: a review of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry 44 (2005) 846-871
39. Poznanski E.O., Grossman J.A., Buchsbaum Y., Banegas M., Freeman L., and Gibbons R. Preliminary studies of the reliability and validity of the children's depression rating scale. Journal of the American Academy of Child Psychiatry 23 (1984) 191-197
40. Ranjekar P.K., Hinge A., Hegde M.V., Ghate M., Kale A., Sitasawad S., Wagh U.V., Debsikdar V.B., and Mahadik S.P. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Research 121 (2003) 109-122
41. Shao L., Young L.T., and Wang J.F. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biological Psychiatry 58 (2005) 879-884
42. Shearman M.S., Sekiguchi K., and Nishizuka Y. Modulation of ion channel activity: a key function of the protein kinase C enzyme family. Pharmacology Reviews 41 (1989) 211-237
43. Soares J.C., Mallinger A.G., Dippold C.S., Frank E., and Kupfer D.J. Platelet membrane phospholipids in euthymic bipolar disorder patients: are they affected by lithium treatment?. Biological Psychiatry 45 (1999) 453-457
44. Soares J.C., Chen G., Dippold C.S., Wells K.F., Frank E., Kuppfer D.J., et al. Concurrent measures of protein kinase C and phosphoinositide in lithium treated bipolar patients and healthy individuals: a preliminary study. Psychiatry Research 95 (2000) 109-118
45. Tanaka C., and Nishizuka Y. The protein kinase C family for neuronal signaling. Annual Review of Neuroscience 17 (1994) 551-567
46. Wang H.Y., and Friedman E. Enhanced protein kinase C activity and translocation in bipolar affective disorder brains. Biological Psychiatry 40 (1996) 568-575
47. Wang H.Y., Markowitz P., Levinson D., Undie A.S., and Friedman E. Increased membrane-associated protein kinase C activity and translocation in blood platelets. Journal of Psychiatric Research 33 (1999) 171-179
48. Wang H.Y., Johnson G.P., and Friedman E. Lithium treatment inhibits protein kinase C translocation in rat brain cortex. Psychopharmacology (Berl) 158 (2001) 80-86
49. Weeber E.J., Atkins C.M., Selcher J.C., Varga A.W., Mirnikjoo B., Paylor R., et al. A role for the beta isoform of protein kinase C in fear conditioning. Journal of Neuroscience 20 (2000) 5906-5914
50. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry 133 (1978) 429-435
51. Young L.T., Wang J.F., Woods C.M., and Robb J.C. Platelet protein kinase C alpha levels in drug-free and lithium-treated subjects with bipolar disorder. Neuropsychobiology 40 (1999) 63-66